Related Experiment Videos

Patent ductus arteriosus in a cohort of 1338 preterm infants: a collaborative study

M van de Bor1, S P Verloove-Vanhorick, R Brand

  • 1Department of Paediatrics, University Hospital, Leiden, The Netherlands.

Insights

Symptomatic patent ductus arteriosus (PDA) affects 10.7% of very preterm infants. Idiopathic respiratory distress syndrome (IRDS), sepsis, and low birthweight are key risk factors for PDA development.

Area of Science:

  • Neonatalogy
  • Perinatal Medicine
  • Pediatric Cardiology

Background:

  • Patent ductus arteriosus (PDA) is a common complication in preterm infants.
  • Understanding PDA incidence and risk factors is crucial for improving neonatal outcomes.

Purpose of the Study:

  • To determine the incidence of symptomatic PDA in infants born at less than 32 weeks gestation or weighing less than 1500 g.
  • To identify maternal and perinatal factors predicting PDA development.
  • To investigate PDA as a predictor for bronchopulmonary dysplasia (BPD) and necrotising enterocolitis (NEC).

Main Methods:

  • Prospective national survey of infants born <32 weeks or <1500 g in the Netherlands.
  • Established PDA presence/absence in infants surviving at least 24 hours.
  • Logistic regression analysis to identify predictive factors for PDA.

Main Results:

  • The incidence of symptomatic PDA was 10.7% in the studied cohort.
  • Idiopathic respiratory distress syndrome (IRDS), septicaemia, birthweight, prolonged rupture of membranes, and gestational age were significant predictors of PDA.
  • PDA was associated with increased risk of BPD and NEC.

Conclusions:

  • IRDS, very preterm birth, and septicaemia are high-risk indicators for PDA.
  • Early identification and management of PDA are essential in high-risk neonates.
  • PDA is a significant risk factor for severe neonatal morbidities like BPD and NEC.

Related Concept Videos